The System for Reporting Adverse Drug Reactions should come with a Warning - 2
The cost to the health system of adverse drug and device reactions is substantial, and failure to act will only lead to more harm.
COVID vaccines
The MHRA's reports on the COVID-19 vaccines, which are updated in line with their summary of the Yellow Card reporting publication. The MHRA Summary of YCS Reporting for COVID-19 vaccines was published on March 8, 2023.
Since January, the reports have focused on the vaccines from the beginning of the Autumn 2022 booster campaign.
As of 22 February 2023 in the UK, 4,096 Yellow Card events were reported for the bivalent COVID-19 Vaccine Pfizer/BioNTech, 5,108 for the bivalent COVID-19 Vaccine Moderna, 57 for the COVID-19 Vaccine Novavax and 2,319 were reported where the brand of the vaccine was not specified.
The MHRA had received 30 UK reports of suspected ADRs with a fatal outcome to the bivalent COVID-19 Pfizer/BioNTech vaccine and 42 fatal reports of suspected ADRs with the bivalent COVID-19 vaccine Moderna. The MHRA received no UK reports of a fatal outcome for the COVID-19 vaccine Novavax.
Interactive reports for each vaccine can be found here:
Keep reading with a 7-day free trial
Subscribe to Trust the Evidence to keep reading this post and get 7 days of free access to the full post archives.